579 related articles for article (PubMed ID: 21552262)
1. A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations.
Toledo LI; Murga M; Zur R; Soria R; Rodriguez A; Martinez S; Oyarzabal J; Pastor J; Bischoff JR; Fernandez-Capetillo O
Nat Struct Mol Biol; 2011 Jun; 18(6):721-7. PubMed ID: 21552262
[TBL] [Abstract][Full Text] [Related]
2. The dual PI3K/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM- and DNA-PKCs-mediated DNA damage responses.
Mukherjee B; Tomimatsu N; Amancherla K; Camacho CV; Pichamoorthy N; Burma S
Neoplasia; 2012 Jan; 14(1):34-43. PubMed ID: 22355272
[TBL] [Abstract][Full Text] [Related]
3. Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR.
Reaper PM; Griffiths MR; Long JM; Charrier JD; Maccormick S; Charlton PA; Golec JM; Pollard JR
Nat Chem Biol; 2011 Apr; 7(7):428-30. PubMed ID: 21490603
[TBL] [Abstract][Full Text] [Related]
4. ATR kinase inhibitors NVP-BEZ235 and AZD6738 effectively penetrate the brain after systemic administration.
Fròsina G; Profumo A; Marubbi D; Marcello D; Ravetti JL; Daga A
Radiat Oncol; 2018 Apr; 13(1):76. PubMed ID: 29685176
[TBL] [Abstract][Full Text] [Related]
5. Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells.
Sultana R; Abdel-Fatah T; Perry C; Moseley P; Albarakti N; Mohan V; Seedhouse C; Chan S; Madhusudan S
PLoS One; 2013; 8(2):e57098. PubMed ID: 23451157
[TBL] [Abstract][Full Text] [Related]
6. Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines.
Peasland A; Wang LZ; Rowling E; Kyle S; Chen T; Hopkins A; Cliby WA; Sarkaria J; Beale G; Edmondson RJ; Curtin NJ
Br J Cancer; 2011 Jul; 105(3):372-81. PubMed ID: 21730979
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ATR-dependent signaling by protoapigenone and its derivative sensitizes cancer cells to interstrand cross-link-generating agents in vitro and in vivo.
Wang HC; Lee AY; Chou WC; Wu CC; Tseng CN; Liu KY; Lin WL; Chang FR; Chuang DW; Hunyadi A; Wu YC
Mol Cancer Ther; 2012 Jul; 11(7):1443-53. PubMed ID: 22532598
[TBL] [Abstract][Full Text] [Related]
8. DNA double-strand break formation upon UV-induced replication stress activates ATM and DNA-PKcs kinases.
Yajima H; Lee KJ; Zhang S; Kobayashi J; Chen BP
J Mol Biol; 2009 Jan; 385(3):800-10. PubMed ID: 19071136
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of autophagy as a strategy to augment radiosensitization by the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
Cerniglia GJ; Karar J; Tyagi S; Christofidou-Solomidou M; Rengan R; Koumenis C; Maity A
Mol Pharmacol; 2012 Dec; 82(6):1230-40. PubMed ID: 22989521
[TBL] [Abstract][Full Text] [Related]
10. Caffeine inhibits checkpoint responses without inhibiting the ataxia-telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) protein kinases.
Cortez D
J Biol Chem; 2003 Sep; 278(39):37139-45. PubMed ID: 12847089
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response.
Nishida H; Tatewaki N; Nakajima Y; Magara T; Ko KM; Hamamori Y; Konishi T
Nucleic Acids Res; 2009 Sep; 37(17):5678-89. PubMed ID: 19625493
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR.
Liu Q; Xu C; Kirubakaran S; Zhang X; Hur W; Liu Y; Kwiatkowski NP; Wang J; Westover KD; Gao P; Ercan D; Niepel M; Thoreen CC; Kang SA; Patricelli MP; Wang Y; Tupper T; Altabef A; Kawamura H; Held KD; Chou DM; Elledge SJ; Janne PA; Wong KK; Sabatini DM; Gray NS
Cancer Res; 2013 Apr; 73(8):2574-86. PubMed ID: 23436801
[TBL] [Abstract][Full Text] [Related]
13. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
Helt CE; Cliby WA; Keng PC; Bambara RA; O'Reilly MA
J Biol Chem; 2005 Jan; 280(2):1186-92. PubMed ID: 15533933
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells.
Tomimatsu N; Mukherjee B; Burma S
EMBO Rep; 2009 Jun; 10(6):629-35. PubMed ID: 19444312
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.
Sarkaria JN; Busby EC; Tibbetts RS; Roos P; Taya Y; Karnitz LM; Abraham RT
Cancer Res; 1999 Sep; 59(17):4375-82. PubMed ID: 10485486
[TBL] [Abstract][Full Text] [Related]
16. ATR-dependent phosphorylation of DNA-dependent protein kinase catalytic subunit in response to UV-induced replication stress.
Yajima H; Lee KJ; Chen BP
Mol Cell Biol; 2006 Oct; 26(20):7520-8. PubMed ID: 16908529
[TBL] [Abstract][Full Text] [Related]
17. Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress.
Liu S; Opiyo SO; Manthey K; Glanzer JG; Ashley AK; Amerin C; Troksa K; Shrivastav M; Nickoloff JA; Oakley GG
Nucleic Acids Res; 2012 Nov; 40(21):10780-94. PubMed ID: 22977173
[TBL] [Abstract][Full Text] [Related]
18. Ku70/80 modulates ATM and ATR signaling pathways in response to DNA double strand breaks.
Tomimatsu N; Tahimic CG; Otsuki A; Burma S; Fukuhara A; Sato K; Shiota G; Oshimura M; Chen DJ; Kurimasa A
J Biol Chem; 2007 Apr; 282(14):10138-45. PubMed ID: 17272272
[TBL] [Abstract][Full Text] [Related]
19. ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress.
Myers K; Gagou ME; Zuazua-Villar P; Rodriguez R; Meuth M
PLoS Genet; 2009 Jan; 5(1):e1000324. PubMed ID: 19119425
[TBL] [Abstract][Full Text] [Related]
20. ATR and H2AX cooperate in maintaining genome stability under replication stress.
Chanoux RA; Yin B; Urtishak KA; Asare A; Bassing CH; Brown EJ
J Biol Chem; 2009 Feb; 284(9):5994-6003. PubMed ID: 19049966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
